Belgium· BE-AMP-SAM661416-00
Radelumin 1300 MBq/ml
A psma-1007 18f product containing (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid, registered in Belgium by Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Psma-1007 18f is registered in 4 of 19 countries.
Countries holding a registration under ATC V09IX17 (psma-1007 18f), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Psma-1007 18f · ATC V09IX17
4 / 19 countries
- Belgiumprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- (3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid
- Manufacturer
- Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
- Country
- Belgium (BE)
- ATC code
- V09IX17
- ATC class
- PSMA-1007 18F
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Psma-1007 18f in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXUMINBlue Earth Diagnostics Ireland Ltd, Dublin
- NorwayAxuminBlue Earth Diagnostics Ireland Ltd
- SwedenAxumin 1600 MBq/ml Injektionsvätska, lösningBlue Earth Diagnostics Ireland Ltd
- NetherlandsAxumin 1600 MBq/ml oplossing voor injectieBlue Earth Diagnostics Ireland Ltd
- FranceAXUMIN 1600 MBq/mL, solution injectableBLUE EARTH DIAGNOSTICS (ROYAUME UNI)
- IrelandAxumin 1,600 MBq/mL solution for injectionBlue Earth Diagnostics Ireland Ltd
- FinlandAxuminBlue Earth Diagnostics Ireland Ltd
- United StatesAxuminBlue Earth Diagnostics
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Radelumin
- Germany · Radelumin
- Spain · Radelumin
- France · Radelumin
- Greece · Próstalumin
- Iceland · Axumin
- Italy · Radelumin
- Liechtenstein · Axumin
- Luxembourg · Radelumin
- Netherlands · Radelumin
- Norway · Axumin
- Poland · Radelumin
- Portugal · Radelumin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba9aa772-887c-4eed-bab2-730cb0960bdd GET /v1/drugs/ba9aa772-887c-4eed-bab2-730cb0960bdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Radelumin 1300 MBq/ml",
"name_fr": "Radelumin 1300 MBq/ml",
"name_nl": "Radelumin 1300 MBq/ml",
"amp_code": "SAM661416-00",
"strengths": [
"1300.0000",
"0.4300",
"0.0380",
"0.0750",
"0.0750",
"10.0000",
"0.0000",
"3.0000"
],
"pack_count": 3,
"substances": [
"(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid",
"Disodium Phosphate",
"Anhydrous Ethanol",
"Potassium Chloride",
"Potassium Dihydrogen Phosphate",
"Sodium Ascorbate",
"Sodium Chloride Solution",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "PSMA-1007 (18F)",
"authorisation_numbers": [
"BE661417",
"BE661416",
"BE661418"
]
}See everything about psma-1007 18f.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.